Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 33

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis

Safirstein, Julie, Grant, Jonathan J., Clausen, Emily, Savant, Deepika, Dezube, Rebecca, Hong, Gina · 2021 · Journal of Cystic Fibrosis

Abstract

Individuals with cystic fibrosis (CF) have an increased risk for gallbladder abnormalities and biliary tract disease, but the reported incidence of these manifestations of CF varies widely in the literature. With the approval of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA), increasing numbers of CF patients have been initiated on highly effective cystic fibrosis transmembrane regulator (CFTR) modulator therapy. While elevations in hepatic panel are known potential side effects of CFTR modulators, there have been no published cases of biliary disease or acute cholecystitis attributed to these medications. In this case series, we describe seven patients at two adult CF centers with biliary colic shortly after initiation with ELX/TEZ/IVA, six of whom required cholecystectomy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcf.2020.07.014

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 11

  1. Assis, 2017, Gallbladder and bile duct disease in cystic fibrosis, J Cyst Fibros, 16, S62, 10.1016/j.jcf.2017.07.006 · DOI
  2. Colombo, 1998, Liver and biliary problems in cystic fibrosis, Semin Liver Dis, 18, 227, 10.1055/s-2007-1007159 · DOI
  3. Curry, 2005, The gallbladder and biliary tract in cystic fibrosis, Curr Gastroenterol Rep, 7, 147, 10.1007/s11894-005-0053-6 · doi:10.1007/s11894-005-0053-6
  4. Ooi, 2016, Cystic fibrosis from the gastroenterologist's perspective, Nat Rev Gastroeneterol Hepatol, 13, 175, 10.1038/nrgastro.2015.226 · DOI · Paper page
  5. Moyer, 2009, Hepatobiliary disease in patients with cystic fibrosis, Curr Opin Gastronenterol, 25, 272, 10.1097/MOG.0b013e3283298865 · doi:10.1097/mog.0b013e3283298865
  6. Cogliandolo, 2011, Postoperative outcomes and quality of life in patients with cystic fibrosis undergoing laparoscopic cholecystectomy: a retrospective study, Surg Laparosc Endosc Percutan Tech, 21, 179, 10.1097/SLE.0b013e318219a2b5 · doi:10.1097/sle.0b013e318219a2b5
  7. Stern, 1986, Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis, J Pediatr Gastronenterol Nutr, 5, 35
  8. Snyder, 1989, Operative therapy of gallbladder disease in patients with cystic fibrosis, Am J Surg, 157, 557, 10.1016/0002-9610(89)90698-3 · doi:10.1016/0002-9610(89)90698-3
  9. McGrath, 1997, Laparoscopic cholecystectomy in adult cystic fibrosis patients, Ir J Med Sci, 166, 70, 10.1007/BF02944189 · doi:10.1007/bf02944189
  10. Cohn, 1993, Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells, Gastroenterology, 105, 1857, 10.1016/0016-5085(93)91085-V · DOI · Paper page
  11. Sakiani, 2019, Hepatic manifestations of cystic fibrosis, Clin Liver Dis, 23, 263, 10.1016/j.cld.2018.12.008 · DOI

Cited by

See all 33

Metadata

Authors
Safirstein, J., Grant, J. J., Clausen, E., Savant, D., Dezube, R., & Hong, G.
Venue
Journal of Cystic Fibrosis
Publisher
Elsevier BV
Published
2021-05
Volume
20
Issue
3
Pages
506-510
ISSN
1569-1993
Cited by
33
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.